We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+16.4%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.04B
AUM Growth
+$345M
Cap. Flow
+$88.5M
Cap. Flow %
4.35%
Top 10 Hldgs %
30.39%
Holding
267
New
71
Increased
36
Reduced
38
Closed
90

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$31.2M
2
PRGO icon
Perrigo
PRGO
+$24.4M
3
ADT
ADT Corp
ADT
+$22.6M
4
M icon
Macy's
M
+$22.2M
5
FFIV icon
F5
FFIV
+$18.7M

Sector Composition

Rank Sector Weight
1 Healthcare 14.95%
2 Consumer Discretionary 7.96%
3 Industrials 7.78%
4 Technology 6.91%
5 Energy 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOS icon
126
Kosmos Energy
KOS
$1.44B
$4.11M 0.2%
400,000
HZNP
127
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.96M 0.19%
1,173,728
+425,100
+57% +$1.12M
OAK
128
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$3.93M 0.19%
75,000
-25,000
-25% -$1.33M
GILD icon
129
Gilead Sciences
GILD
$168B
$3.63M 0.18%
57,800
-66,200
-53% -$3.96M
AGN
130
DELISTED
Allergan plc
AGN
$3.6M 0.18%
+25,000
New +$3.33M
EDG
131
DELISTED
EDGEN GROUP INC CLASS A COM STK
EDG
$3.55M 0.17%
467,400
-135,856
-23% -$1.04M
GTN icon
132
Gray Television
GTN
$441M
$3.53M 0.17%
+450,000
New +$3.37M
HLF icon
133
Herbalife
HLF
$1.33B
$3.49M 0.17%
+100,000
New +$3.09M
SBGI icon
134
CALL
Sinclair Inc
SBGI
$1.01B
$3.35M 0.16%
100,000
OPK icon
135
Opko Health
OPK
$978M
$3.28M 0.16%
372,673
+297,673
+397% +$2.39M
PCRX icon
136
Pacira BioSciences
PCRX
$1.09B
$3.26M 0.16%
67,784
-9,000
-12% -$328K
ITMN
137
CALL
DELISTED
INTERMUNE INC
ITMN
$3.08M 0.15%
+200,000
New +$2.81M
DNKN
138
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$3.03M 0.15%
66,902
-28,478
-30% -$1.25M
XPRO icon
139
Expro Ltd
XPRO
$1.88B
$2.99M 0.15%
+16,667
New +$2.81M
TILE icon
140
Interface
TILE
$2.01B
$2.98M 0.15%
150,000
TGI
141
DELISTED
Triumph Group
TGI
$2.95M 0.14%
+42,000
New +$3.24M
JAH
142
DELISTED
JARDEN CORPORATION
JAH
$2.66M 0.13%
+82,500
New +$2.55M
GGG icon
143
Graco
GGG
$13.3B
$2.44M 0.12%
+98,817
New +$2.32M
CELG
144
DELISTED
Celgene Corp
CELG
$2.4M 0.12%
+31,152
New +$2.18M
ATRS
145
DELISTED
Antares Pharma, Inc.
ATRS
$2.33M 0.11%
575,000
+75,000
+15% +$328K
LPNT
146
DELISTED
LifePoint Health, Inc.
LPNT
$2.29M 0.11%
49,000
AMGN icon
147
Amgen
AMGN
$210B
$2.24M 0.11%
+20,000
New +$2.17M
DVAX
148
DELISTED
Dynavax Technologies
DVAX
$2.16M 0.11%
181,499
THC icon
149
Tenet Healthcare
THC
$20.4B
$2.08M 0.1%
50,600
CYH icon
150
Community Health Systems
CYH
$417M
$2.08M 0.1%
60,500
-6,050
-9% -$215K

Similar funds

Kingdon Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Kingdon Capital Management held 267 positions worth $2.04B, up 20% from $1.69B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Kingdon Capital Management deployed $88.5M of net new capital in Q3 2013, opening 71 new positions and adding to 36 existing holdings. Its largest new stake was Boeing: 289,450 shares worth $34M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Micron Technology, an estimated $10.2M trimmed.

  • Kingdon Capital Management's largest Q3 2013 buy was Boeing: 289,450 shares worth $34M.
  • Kingdon Capital Management added most to ADT Corp in Q3 2013, an estimated $22.6M increase.
  • Kingdon Capital Management's biggest Q3 2013 reduction was Micron Technology, cutting an estimated $10.2M.
  • Kingdon Capital Management fully exited SANDISK CORP in Q3 2013, selling an estimated $22.6M.
  • Kingdon Capital Management's ten largest holdings make up 30% of its $2.04B portfolio in Q3 2013.
  • Kingdon Capital Management opened 71 new positions and closed 90 in Q3 2013.
  • Kingdon Capital Management's portfolio value rose 20% quarter-over-quarter to $2.04B.

Based on Kingdon Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.